We apologize for Proteopedia being slow to respond. For the past two years, a new implementation of Proteopedia has been being built. Soon, it will replace this 18-year old system. All existing content will be moved to the new system at a date that will be announced here.

Rapamycin

From Proteopedia

(Difference between revisions)
Jump to: navigation, search

Karsten Theis (Talk | contribs)
(New page: '''Rapamycin''' is an immuno-suppressant and anticancer drug. It acts by binding the the mTORC1 protein complex, a kinase that regulates cell growth and metabolism. In the future, it might...)
Next diff →

Revision as of 14:10, 17 July 2019

Rapamycin is an immuno-suppressant and anticancer drug. It acts by binding the the mTORC1 protein complex, a kinase that regulates cell growth and metabolism. In the future, it might also be used in treatment of type 2 diabetes[1].

Structure

Caption for this structure

Drag the structure with the mouse to rotate

References

  1. ↑ https://doi.org/10.3389/fphar.2016.00395
  2. ↑ Marz AM, Fabian AK, Kozany C, Bracher A, Hausch F. Large FK506-binding Proteins Shape the Pharmacology of Rapamycin. Mol Cell Biol. 2013 Jan 28. PMID:23358420 doi:http://dx.doi.org/10.1128/MCB.00678-12

Proteopedia Page Contributors and Editors (what is this?)

Karsten Theis

Retrieved from "http://52.214.119.220/wiki/index.php/Rapamycin"
Personal tools